samedan logo
 
 
 
spacer
home > ebr > spring 2021 > beyond cold
PUBLICATIONS
European Biopharmaceutical Review

Beyond Cold

Without a doubt, 2020 was an unusual year. The SARSCoV-2 pandemic reshaped how we work, live, learn, and interact at every level. The global response, however, was unprecedented. The imperative to contain the virus pushed the vaccine industry into the public spotlight and the outcome was disruptive: a new generation of vaccines emerged that has redefined immunisation strategies.

A New Era in Vaccine Storage

Vaccines based on novel mRNA and viral vector technologies are in line to bring the world back to normalcy. Developed, tested, and approved in record time, these vaccines have changed how industry produces, manages, and – above all – moves immunisations through the cold chain from manufacturing sites to anxiously waiting end users. Within the span of just 11 months, the transport and storage of vaccines at -70°C became a global priority. Before last year, ultra-low temperature (ULT) had only been used for the highly localised delivery of trial vaccines during Ebola outbreaks.

Until now, most vaccines were commonly stored between 2°C and 8°C worldwide. Consequently, the existing cold chain infrastructure built on standard refrigerators and freezers was insufficient to accommodate these new ULT storage needs. In anticipation and support of these new vaccine modes, and facing the largest immunisation campaign in human history, cold chain infrastructure is expanding to reach far below sub-zero temperatures and adding storage facilities to accommodate massive numbers of doses.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Dr Alex Esmon is Senior Director/General Manager for Cold Storage at the laboratory products division of Thermo Fisher Scientific. With a PhD in Molecular Biology from the University of Missouri, Columbia, US, Dr Esmon has over 13 years of experience in industry and has overseen almost all aspects of managing products for cold storage and cryopreservation.
Print this page
Send to a friend
Privacy statement
News and Press Releases

Advanced Clinical Continues Global Expansion Into Asia-Pacific With New Office in Australia

Advanced Clinical, a global clinical research services organization, continues to build upon its growth strategy in the Asia-Pacific (APAC) region with the opening of a new office in Sydney, Australia.
More info >>

White Papers

The Flexible Factory Concept: A flexible bioprocessing platform to meet the changing needs of biomanufacturing

GE Healthcare Life Sciences

For the past several years, the biopharma industry has been buffeted by dynamic market conditions that are rapidly reshaping manufacturing requirements. These factors include: • The rise of small-market pharmaceuticals that do not require the production scale of the previous “blockbuster” drug model • Increased titers and process productivity that generate more bulk-product within a much smaller manufacturing footprint • The emergence of biosimilars and continued evolution of healthcare reform, which will increasingly pressure drug pricing and require greater cost discipline • Greater competition and shorter patent protection timelines, which will further ratchet up time-to-market pressures • Tighter capital markets that will create heightened scrutiny for all new investment projects
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement